TY  - RPRT
TI  - A Reanalysis of the FDA's Benefit--Risk Assessment of Moderna's mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection
AU  - Paul S. Bourdon
AU  - Ram Duriseti
AU  - H. Christian Gromoll
AU  - Dyana K. Dalton
AU  - Kevin Bardosh
AU  - Allison E. Krug
PY  - 2026
UR  - https://arxiv.org/abs/2410.11811
ID  - 2410.11811
ER  -